Ashmore upgraded amidst emerging markets turning point

Jefferies upgraded Ashmore Group to 'buy' and raised its price target to 285p, applying a 13x multiple to 2027 earnings, citing Q4 2025 as a turning point in the emerging markets cycle. Ashmore delivered $2.6bn of net new money in the quarter with more than 20% annualised inflow pace and roughly half of gross inflows from new institutional mandates, suggesting durable rebuilding of EM exposure; equities and alternatives now represent ~20% of AUM and ~30% of fees, improving margin diversity. Jefferies frames this as the first phase of a potential multi-quarter recovery in flows and sees an attractive risk-reward if institutional inflows broaden.

Analysis

Market structure: A sustained re‑acceleration of EM fund flows (Ashmore reported $2.6bn NNM in Q4 2025 and a >20% annualised inflow run‑rate) directly benefits active EM asset managers with institutional distribution (ASHM.L), EM equity and EM credit markets, and commodity exporters. Losers are safe‑haven cash/DM sovereign bonds and managers reliant on passive US dollar cash‑flow; if institutional mandates rebuild allocations rather than tactical top‑ups, fee mix and AUM durability improve materially.

Competitive dynamics & supply/demand: Managers with differentiated, higher‑margin products (equities, alternatives — ~20% AUM at Ashmore) gain pricing power and can absorb rate of inflows without excessive fee pressure; passive products may see slower net share gains. Net demand into EM bonds/equities should tighten spreads and push local yields/currencies stronger — a sustained $1bn+/qtr industry inflow would compress USD‑EM spread by 50–150bp over 6–12 months in stressed names.

Risk assessment & catalysts: Tail risks include a China growth shock, geopolitics, or a reversal in global rates that re‑raises US real yields; these could flip flows in 1–3 months. Key catalysts are Q1/Q2 2026 institutional mandate wins (threshold: >$1bn NNM per quarter for continuation), EM performance vs DM over 3 months, and Ashmore’s quarterly flow disclosures.

Trade implications & contrarian view: Market may underprice the path‑dependence of flows — recovery tends to be lumpy but can accelerate; however, durability requires outperformance and diversification of client base. If flows don’t broaden beyond institutions or performance lags, active managers can quickly re‑devolve to discount, so size positions accordingly and use option structures to cap downside.

Key Decisions for Investors

• Establish a tactical 2–3% long position in Ashmore Group (LSE:ASHM) within 2–6 weeks using a staggered entry (1/3 now, 1/3 on confirmation of next quarter NNM > $1bn, final tranche on >$2bn cumulative). Set target 285p (Jefferies PT) and hard stop at 30% below entry; trim half of position if quarterly NNM falls below zero.
• Allocate 1–2% to EM duration via iShares J.P. Morgan USD Emerging Markets Bond ETF (NYSEARCA:EMB) with a 3–12 month horizon to capture spread tightening; exit or hedge if US 10y real yield rises >75bp from current level or EMB underperforms global sovereign bonds by >3% in 2 months.
• Implement a leveraged, limited‑risk options trade on Ashmore: buy a 9–12 month call spread sized to 1% portfolio risk (e.g., buy Jan‑Feb 2027 calls and sell higher‑strike calls around 285p) to capture multi‑quarter re‑rating while capping premium outlay.
• Pair trade for relative value: go long ASHM.L (1.5% portfolio) and short Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO) (0.75% notional) to express active‑manager rerating vs passive — unwind if ASHM underperforms VWO by >8% in 60 days or if institutional NNM signals reverse.
• Increase tactical exposure to commodity‑exporter FX and equities (Brazil: EWZ 0.5–1%; Mexico: EWW 0.5%) via ETFs or forwards with 3–9 month horizons, scaling out if BRL or MXN appreciate >10% vs USD or if MSCI EM underperforms MSCI World by >5% in 2 months.